Monte Carlo simulation on the effect of different approaches to thalassaemia on gene frequency

Eastern Mediterranean Health Journal

Volumn 12, Issue 1-2, 2006, Pages 196-203

  Habibzadeh, F ^a   Yadollahie, M ^a  

^a NATIONAL IRANIAN OIL COMPANY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MONTE CARLO METHOD; PHENOTYPE; PRENATAL DIAGNOSIS; THALASSEMIA; THERAPEUTIC ABORTION;

ABORTION, THERAPEUTIC; BONE MARROW TRANSPLANTATION; COST OF ILLNESS; FEMALE; GENE FREQUENCY; GENETIC COUNSELING; GENETIC SCREENING; GENETIC TESTING; GENETIC VARIATION; GENOTYPE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; INHERITANCE PATTERNS; IRAN; MALE; MARRIAGE; MONTE CARLO METHOD; PHENOTYPE; PRENATAL DIAGNOSIS; THALASSEMIA; TREATMENT OUTCOME; VARIATION (GENETICS);

EID: 33748415481     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lukens JN. The thalassaemia and related disorders, quantitative disorders of haemoglobin synthesis. In: Lee GR et al., eds. Wintrobe's clinical haematology, 9th ed. Philadelphia, Lea & Febiger, 1993: 1102-45.
2. Habibzadeh F et al. Thalassaemia in Iran: an overview. Archives of Iranian medicine, 1998, 1(1):27-33.
3. Ghani R, Manji MA, Ahmed N. Hemoglobinopathies among five major ethnic groups in Karachi, Pakistan. Southeast Asian journal of tropical medicine and public health, 2002, 33(4):855-61.
4. Bonate PL. A brief introduction to Monte Carlo simulation. Clinical pharmacokinetics, 2001, 40(1):15-22.
5. Matsumoto M, Nishimura T. Mersenne twister: a 623-dimensionally equidistributed uniform pseudo-random number generator. ACM transactions on modeling and computer simulation, 1998, 8(1): 3-30.
6. Pearson HA et al. The changing profile of homozygous beta-thalassaemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades. Pediatrics, 1996, 97(3):352-6.
7. Thompson JS, Thompson MW. Genetics in medicine, 3rd ed. Philadelphia, WB Saunders, 1980:290-3.
8. Cao A, Rosatelli MC, Galanello R. Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: the Sardinian experience. Ciba Foundation symposium, 1996, 197: 137-51.
9. Ghanei M et al. Pre-marriage prevention of thalassaemia: report of a 100 000 case experience in Isfahan. Public health, 1997, 111(3):153-6.
10. Keskin A et al. Premarital screening of beta-thalassaemia trait in the province of Denizli, Turkey. Acta haematologica, 2000, 104(1):31-3.
11. Perera DM et al. Thalassaemia control in developing countries - the Sri Lankan perspective. Ceylon medical journal, 2000, 45(1):12-6.
12. Oliva Berini E, Cladera Serra A, Torrent Quetglas M. Campaña para la detección de la betatalasemia minor y prevención de la major en la isla de Menorca. Experiencia de 10 anos [Campaign for the detection of minor beta-thalassaemia and prevention of major beta-thalassaemia in the isle of Menorca. 10-year experience]. Medicina clínica, 1998, 110(10):361-4.
13. Wanapirak C et al. Prenatal strategies for reducing severe thalassaemia in pregnancy. International journal of gynaecology and obstetrics, 1998, 60(3):239-44.